Evidence map›Paper›PMID 22218224›Full record

ArticleGenes and immunity2012

Genetic association of miRNA-146a with systemic lupus erythematosus in Europeans through decreased expression of the gene.

S E Löfgren, J Frostegård, L Truedsson, B A Pons-Estel, S D'Alfonso, T Witte, B R Lauwerys, E Endreffy, L Kovács, C Vasconcelos and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Genes and immunity, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 80 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
80citing papers in PubMed, 8 pooled it
6.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

80 citing papers in PubMed, 8 syntheses or guidelines pooled it, 151 citations in OpenAlex.

  1. Pooled it
  2. Genetic variant inAnnals of medicine · 2021
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. miR-146a mimic therapy protects against platelet-mediated thrombosis.Molecular therapy : the journal of the American Society of Gene Therapy · 2026
    Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Cross Talk between MicroRNAs and Dengue Virus.The American journal of tropical medicine and hygiene · 2024
    Review
  18. Article
  19. Article
  20. MiRNA-146a-A Key Player in Immunity and Diseases.International journal of molecular sciences · 2023
    Review

20 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 9 institutions in 8 countries.

S E LöfgrenDepartment of Immunology, Genetics and Pathology, Rudbeck Laboratory, Uppsala University, Uppsala, Sweden.
J Frostegård
L Truedsson
B A Pons-Estel
S D'Alfonso
T Witte
B R Lauwerys
E Endreffy
L Kovács
C Vasconcelos
B Martins da Silva
S V Kozyrev
M E Alarcón-Riquelme
University of Szeged · HUUppsala University · SEHospital de Santo António · PTKarolinska University Hospital · SELund University · SEMedizinische Hochschule Hannover · DEUCLouvain · BEUniversidad de Granada · ESUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro” · IT

Funding

SNP Confirmation and High Throughput Genotyping CoreP30AR053483 · NIAMS · OKLAHOMA MEDICAL RESEARCH FOUNDATION · PI GUTHRIDGE, JOEL MARVIN · 2007 to 2017
$6.7M
NIAMS NIH HHS P30 AR053483
6 · The paper itself

Abstract

A recent genome-wide association study revealed a variant (rs2431697) in an intergenic region, between the pituitary tumor-transforming 1 (PTTG1) and microRNA (miR-146a) genes, associated with systemic lupus erythematosus (SLE) susceptibility. Here, we analyzed with a case-control design this variant and other candidate polymorphisms in this region together with expression analysis in order to clarify to which gene this association is related. The single-nucleotide polymorphisms (SNPs) rs2431697, rs2910164 and rs2277920 were genotyped by TaqMan assays in 1324 SLE patients and 1453 healthy controls of European ancestry. Genetic association was statistically analyzed using Unphased. Gene expression of PTTG1, the miRNAs miR-3142 and primary and mature forms of miR-146a in peripheral blood mononuclear cells (PBMCs) were assessed by quantitative real-time PCR. Of the three variants analyzed, only rs2431697 was genetically associated with SLE in Europeans. Gene expression analysis revealed that this SNP was not associated with PTTG1 expression levels, but with the microRNA-146a, where the risk allele correlates with lower expression of the miRNA. We replicated the genetic association of rs2341697 with SLE in a case-control study in Europeans and demonstrated that the risk allele of this SNP correlates with a downregulation of the miRNA 146a, potentially important in SLE etiology.

Indexed as

Gene Expression RegulationGenetic Predisposition to DiseaseAllelesCase-Control StudiesEuropeGene OrderGenome-Wide Association StudyHumansLupus Erythematosus, SystemicMicroRNAsNeoplasm ProteinsPolymorphism, Single NucleotideSecurinWhite PeopleMicroRNAsMIRN146 microRNA, humanNeoplasm Proteinspituitary tumor-transforming protein 1, humanSecurin

Identifiers

PMID22218224
PMCPMC3640319
OpenAlexW1976676604

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.